Anju Bhardwaj MD FACC

Time for #CardiogenicShock guidelines?
Our @JACCJournals #JACCAdvances State-of-the-Art Review: Evolving evidence across CS phenotypes, hemodynamics & #MCS & where guidance needs to evolve.
👉 jacc.org/doi/10.1016/j.…

Shaped by expertise & insights of an all 🌟 coauthor team

Kudos to the Program Committee for an outstanding #HFSA2026. Grateful for great science, meaningful conversations, and time with mentors & friends across the #HF community. Proud to highlight the multidisciplinary work at @uvahealthnews
in #AHF, #MCS #ECMO & #prehabilitation

In advanced HF, the survival equation changes on counting waitlist time in older patients; decisions must consider entire treatment journey, not just post-therapy outcomes.
Now in @JACCJournals #JACCHF
jacc.org/doi/10.1016/j.…

@NirUrielMD @yuzefpolskaya @ilanrichter et al

That’s a wrap! #ISHLT2026
Inspiring colleagues, valued friendships & strong science advancing #HT & #MCS.
#HeartRecovery took center stage, grateful to be part of the dialogue🫀
Kudos to the Program Committee for an outstanding program & @ISHLT team for making it seamless.

Hypotension with #Finerenone common, not prohibitive! #GDMTWorks

🔑 Don’t stop therapy reflexively
➡️ Monitor closely; benefits despite hypotension #HFpEF #HFmrEF

@mvaduganathan @safchat @lamcardio @HFpEF @FaiezZANNAD
Read in @JACCJournals #JACCHF
👉 jacc.org/doi/10.1016/j.…